Cooper Companies Q3 Preview: Low Fertility Growth During Year Of Snake Is Temporary

An analyst has reiterated a Buy rating on The Cooper Companies (COO) with a fair value of $86 per share, despite recent stock underperformance. The temporary weakness in the fertility segment, attributed to cultural factors in APAC, is not expected to impede overall robust growth. The company projects 7% revenue growth for FY25, accelerating to 8% from FY26, supported by anticipated margin expansion, manageable debt levels, and resuming share repurchases, reinforcing long-term growth prospects.

Analysis

An analyst has reiterated a buy rating on The Cooper Companies (COO) with a price target of $86 per share, framing the stock's recent underperformance as a temporary dislocation. The primary headwind identified is a slowdown in the fertility segment, specifically attributed to temporary cultural factors in the APAC region related to the 'Year of the Snake,' which is not expected to derail the company's overall robust growth trajectory. The outlook remains positive, with revenue projected to grow 7% in FY25 before accelerating to an 8% growth rate from FY26 onward. This growth is expected to be supported by margin expansion, driven by effective pricing strategies and cost control measures. Furthermore, the company's financial position is solid, characterized by manageable debt levels and the resumption of its share repurchase program, signaling management's confidence in long-term prospects.

Key Decisions for Investors

• Investors should evaluate if the current stock underperformance presents a buying opportunity, based on the thesis that the fertility segment's weakness is a short-term, culturally-driven issue.
• Monitor upcoming earnings reports for confirmation of the projected 7% revenue growth for FY25 and any stabilization or recovery in the APAC fertility business.
• Consider the resumption of share repurchases as a key positive signal of management's confidence and a potential driver of shareholder value, alongside the execution of margin expansion initiatives.